You are here: Industry Insights > COVID-19

News List

AZ kicks off PhI trial of potential COVID-19 therapy pharmatimes
August 26, 2020
AstraZeneca has dosed the first participants in a Phase I trial of AZD7442, a combination of two monoclonal antibodies (mAbs) being developed for prevention and treatment of COVID-19.
Clinical research cut 87% at peak of pandemic pharmatimes
August 26, 2020
At the peak of the COVID-19 pandemic, clinical research capacity may have been slashed by up to 87% in England, according to a new study led by UCL academics.
No increased risk from COVID-19 for healthy pregnant women pharmatimes
August 26, 2020
Healthy pregnant women are not at higher risk of falling seriously ill from COVID-19 than healthy women not pregnant, suggests a study from King's College London.
FDA Provides Update on Pooled Sample Testing and Screening Testing for COVID-19 americanpharmaceuticalreview
August 26, 2020
The U.S. Food and Drug Administration (FDA) has taken steps to encourage the development of tests for screening asymptomatic individuals and for testing pooled samples, as summarized in the June 16, 2020 ...
Innovation’s Brilacidin shows promise in-vitro against Covid-19 pharmaceutical-technology
August 26, 2020
Innovation Pharmaceuticals has reported promising data from ongoing in-vitro testing of its Brilacidin at a US Regional Biocontainment Laboratory (RBL) to treat Covid-19.
FDC launches two favipiravir variants for COVID-19 treatment expresspharma
August 26, 2020
FDC announced the launch of two variants of favipiravir – PiFLU and Favenza – which will be used to treat mild to moderate cases of COVID-19 in India.
Nasal vaccine against COVID-19 prevents infection in mice worldpharmanews
August 25, 2020
Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus.
Medicure Announces AGGRASTAT? Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports prnewswire
August 25, 2020
Medicure Inc., a pharmaceutical company, is reporting that early investigator sponsored clinical reports evaluating the efficacy of AGGRASTAT? (tirofiban hydrochloride) show promise for preventing and treating thrombotic complications due to COVID-19.
COVID-19 Vaccine Candidate Enters Phase 1 Study with First Healthy Volunteer americanpharmaceuticalreview
August 25, 2020
ReiThera has announced the first healthy volunteer has been dosed in a Phase 1 study of the Company's vaccine candidate (GRAd-COV2) against the novel coronavirus (SARS-CoV-2).
USPTO grants patent to Tiziana for fully human monoclonal antibody, TZLS-501 expresspharma
August 25, 2020
The grant of this additional patent on TZLS-501 is of significance for the potential treatment of COVID-19 and other pulmonary diseases.